NCT00023712 · Interventional trial
Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Overall registry status Completed
Phase 2
Conditions Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
Delaware Valley sites
- Gynecologic Oncology Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory